1136832-72-8

Basic information

• Product Name: 4-(3-(4-(4-(trifluoromethyl)phenoxy)phenyl)-1,2,4-oxadiazol-5-yl)phenol
• Synonyms: 4-(3-(4-(4-(trifluoromethyl)phenoxy)phenyl)-1,2,4-oxadiazol-5-yl)phenol
• CAS NO: 1136832-72-8
• Molecular Weight: 398.341
• Mol File: 1136832-72-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 4-(3-(4-(4-(trifluoromethyl)phenoxy)phenyl)-1,2,4-oxadiazol-5-yl)phenol(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-(4-(4-(trifluoromethyl)phenoxy)phenyl)-1,2,4-oxadiazol-5-yl)phenol(1136832-72-8)
• EPA Substance Registry System: 4-(3-(4-(4-(trifluoromethyl)phenoxy)phenyl)-1,2,4-oxadiazol-5-yl)phenol(1136832-72-8)

Safety Data

• Hazardous Substances Data: 1136832-72-8(Hazardous Substances Data)

Upstream product

• 1567711-31-2 5-(4-(tert-butyldimethylsilyloxy)phenyl)-3-(4-(4-(trifluoromethyl)phenoxy)-phenyl)-1,2,4-oxadiazole 
• 99-96-7 4-hydroxy-benzoic acid 
• 860004-31-5 4-(4-(trifluoromethyl)phenoxy)benzonitrile 
• 3058-39-7 4-iodobenzonitrile 
• 402-45-9 4-hydroxybenzotrifluoride 
• 78324-14-8 tert-butyldimethylsilyl 4-((tert-butyldimethylsilyl)oxy)benzoate 
• 1166388-13-1 C₂₈H₁₉F₃N₂O₃ 

Relevant articles and documents

Discovery of a new class of non-β-lactam inhibitors of penicillin-binding proteins with gram-positive antibacterial activity

Infections caused by hard-to-treat methicillin-resistant Staphylococcus aureus (MRSA) are a serious global public-health concern, as MRSA has become broadly resistant to many classes of antibiotics. We disclose herein the discovery of a new class of non-β-lactam antibiotics, the oxadiazoles, which inhibit penicillin-binding protein 2a (PBP2a) of MRSA. The oxadiazoles show bactericidal activity against vancomycin-and linezolid-resistant MRSA and other Gram-positive bacterial strains, in vivo efficacy in a mouse model of infection, and have 100% oral bioavailability.

ANTIBACTERIAL COMPOUNDS AND METHODS OF USING SAME

Embodiments of the present invention provide novel antibactehals that target penicillin-binding proteins or other important cellular targets. Methods for inhibiting growth (reproduction, etc.) of bacteria using compounds described herein are also provided. Various embodiments exhibit activity against gram positive bacteria, such as certain strains of Entercoccus and Staphylococcus aureus.